146 related articles for article (PubMed ID: 26045113)
1. Bioinformatics approach reveals systematic mechanism underlying lung adenocarcinoma.
Wu X; Zhang W; Hu Y; Yi X
Tumori; 2015; 101(3):281-6. PubMed ID: 26045113
[TBL] [Abstract][Full Text] [Related]
2. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
4. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer.
Lv M; Wang L
Exp Lung Res; 2015 Mar; 41(2):74-83. PubMed ID: 25514196
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
Lu C; Chen H; Shan Z; Yang L
Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
[TBL] [Abstract][Full Text] [Related]
8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
9. Pathway crosstalk analysis of non-small cell lung cancer based on microarray gene expression profiling.
Xing C; Zhang R; Cui J; Li Y; Li G; Yang Y; Pang L; Ruan X; Li J
Tumori; 2015; 101(1):111-6. PubMed ID: 25702679
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer.
Wang CY; Chao YJ; Chen YL; Wang TW; Phan NN; Hsu HP; Shan YS; Lai MD
Int J Med Sci; 2021; 18(1):256-269. PubMed ID: 33390794
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
Chen B; Gao S; Ji C; Song G
Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
[TBL] [Abstract][Full Text] [Related]
12. Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Li TT; Gao X; Gao L; Gan BL; Xie ZC; Zeng JJ; Chen G
Pathol Res Pract; 2018 May; 214(5):750-766. PubMed ID: 29526559
[TBL] [Abstract][Full Text] [Related]
13. Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing.
Yang ZH; Zheng R; Gao Y; Zhang Q; Zhang H
Cancer Gene Ther; 2014 Feb; 21(2):74-82. PubMed ID: 24503571
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue.
Zhang W; Gong W; Ai H; Tang J; Shen C
Tumori; 2014; 100(3):338-45. PubMed ID: 25076248
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes and crucial modules associated with coronary artery disease by bioinformatics analysis.
Zhang X; Cheng X; Liu H; Zheng C; Rao K; Fang Y; Zhou H; Xiong S
Int J Mol Med; 2014 Sep; 34(3):863-9. PubMed ID: 24969630
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
[TBL] [Abstract][Full Text] [Related]
20. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]